No images? Click here
Domainex News
All the latest news and industry insights from the Domainex team
Tom Mander, CEO
Domainex turns 20!
Welcome back to everyone after the summer, I hope you all managed some time off for a relaxing break. It really feels like Autumn is finally on its way after a warm September, with days drawing in noticeably (I’m now walking our new lockdown puppy in the dark!). With very high uptake of the vaccines at Domainex, we’re just starting to have everyone back working Monday-Friday after operating a shift pattern across 7 days/week these past 18 months.
In November, Domainex will turn 20 and to celebrate this milestone we decided to take a look back at how the company and the industry have changed over the last two decades. Domainex started life in 2001 as a spin-out from University College London, Birkbeck College and the Institute of Cancer Research. Since then, drug discovery technology has transformed and we have along with it, growing and learning to continue to offer our clients the best drug discovery expertise.
We’ll be announcing some exciting celebrations to mark this occasion very soon, so keep an eye on our website and social media to help us celebrate. Why not take a look at our latest news in the meantime.
I hope you all enjoy the remaining few months of 2021.
Tom
E: Tom.Mander@dominex.co.uk
Domainex celebrates 20 years in Drug Discovery
This year Domainex celebrates its 20th anniversary: 20 years of innovation, enriching our clients’ medicines pipelines with the latest technologies and a wealth of drug discovery expertise.
Synthesis in Review: A look at the latest developments in synthetic chemistry from O-arylation to indole expansion
We regularly review the literature to make sure we are aware of the latest developments. In the first of our synthetic chemistry review blogs, we have selected two recently published papers to focus on. Read more.
Meet the Domainex Team: Chris Matheson
The next blog in the series introduces Associate Principal Scientist, Chris. He shares his experience of his first year working at Domainex in the medicinal chemistry team using his expertise to drive client drug discovery projects from early hit-to-lead through to lead optimisation and identification of a clinical candidate. Read more.
Welcome to the team
We've grown again and are excited to welcome Hannah McNeil (Commercial Operations Scientist), Rachel Pearce (Associate Director of Business Development), Estina Madamombe (Scientist, Assay Biology), Cameron Haddow (Scientist, Assay Biology), Jessica McCabe (Placement Student, Protein Science), Amy Dunn (Placement Student, Chemistry) and Rebecca Midgley (Placement Student, Chemistry). Find out more about joining our experienced team.
Design, synthesise, analyse – from hit compounds to candidate drugs
To have a successful small-molecule drug research project you will need a high-quality medicinal chemistry team, and the chemists at Domainex are among the very best in the business. Contact us today to find out how we can help progress your chemistry projects from hit identification through lead generation and optimisation, to the nomination of promising drug candidates.
New publications
Fragment library screening by Grating Coupled Interferometry (GCI) and the benefits over Surface Plasmon Resonance (SPR) – Presentation and Poster
Assay Biology: Customised biophysical, biochemical and cell-based assays to meet your needs
Cell Accumulation and Fraction Unbound bridge the gap between enzyme and cellular assay disconnects
Follow us on social media
Upcoming events
ELRIG: Drug Discovery 2021
19-20th October | Liverpool
If you are attending, please come and see us at our booth or at one of our posters. Tom Mander (CEO), Catherine Stace (Director of Business Development), Mark Stewart (Team Leader, Chemistry), Sam Braidley (Senior Scientist, Analytical Chemistry) and Nick Bland (Principal Scientist, Assay Biology) will be in attendance and delighted to discuss your requirements.
ELRIG: Discovery Technologies 2021
9-10th November | Alderley Park
We’ll be exhibiting at this event too so please come and say hello to David Cronk (Chief of Staff), Trevor Askwith (Group Leader, Assay Biology), Jana Wolf (Team Leader, Assay Biology) and Rachel Pearce (Associate Director of Business Development) and learn about the exciting new developments at Domainex.
PSDI 2021 - 29th Protein Structure Determination in Industry Meeting
8-10th November
We will be attending and sponsoring this online event.
